Details for Netherlands Supplementary Protection Certificate: C300213
✉ Email this page to a colleague
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0451216 | C300213 | Netherlands | PRODUCT NAME: OMALIZUMAB, OF FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/05/319/001-002 20051025 | ⤷ Try a Trial |